{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:46Z","timestamp":1783416346107,"version":"3.54.6"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The study aimed to quantify the acute tear-film disruption in treatment-naive, 1st-onset noninfectious acute anterior uveitis (AAU) and identify independent and modifiable determinants. Retrospective case-control study enrolling 180 AAU eyes and 90 age-\/sex-matched healthy controls. Same-day noninvasive tear breakup time (NIBUT), tear meniscus height, Schirmer-I and Ocular Surface Disease Index were extracted. Multivariable linear regression with bootstrap correction determined predictors of shorter NIBUT. Mean NIBUT was 4.7 seconds lower in AAU than controls (5.7\u2005\u00b1\u20051.5 seconds vs 10.4\u2005\u00b1\u20051.5 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001); 66% of AAU eyes versus 2% of controls had NIBUT\u2005\u2264\u20055 seconds. Tear meniscus height (\u221281 \u03bcm), Schirmer-I (\u22125.3\u2009mm) and Ocular Surface Disease Index (+24 points) all worsened (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Independent reductions in NIBUT: anterior-chamber cells\u2005\u2265\u20052+ (\u22121.79 seconds), flare\u2005\u2265\u20053+ (\u22121.23 seconds), concomitant meibomian gland dysfunction (\u22120.96 seconds) and daily screen time\u2005&gt;\u20058 hours (\u22120.59 seconds); adjusted\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20050.38, optimism-corrected\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u20050.35. In this proof-of-concept study, 1st-onset AAU was associated with measurable tear-film destabilization driven by intraocular inflammatory load. While these findings suggest a potential role for early ocular-surface protection, effect sizes represent upper-bound estimates requiring confirmation in unscreened populations before routine clinical application.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048825","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:49Z","timestamp":1779469249000},"page":"e48825","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acute tear-film disruption in treatment-naive acute anterior uveitis: A retrospective case-control study"],"prefix":"10.1097","volume":"105","author":[{"given":"Zheren","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tongxiang First People\u2019s Hospital, Tongxiang City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuankai","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongxiang First People\u2019s Hospital, Tongxiang City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9964-5738","authenticated-orcid":false,"given":"Bihua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongxiang First People\u2019s Hospital, Tongxiang City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"671417","DOI":"10.1155\/2015\/671417","article-title":"Macrophages and uveitis in experimental animal models.","volume":"2015","author":"M\u00e9rida","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"Suppl 1","key":"R2-20260707","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome: dry eye disease and associated tear film disorders \u2013 new strategies for diagnosis and treatment.","volume":"27","author":"Milner","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"101033","DOI":"10.5662\/wjm.v15.i4.101033","article-title":"Diagnostic methods for managing dry eyes.","volume":"15","author":"Musa","year":"2025","journal-title":"World J Methodol"},{"key":"R4-20260707","first-page":"113","article-title":"Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium.","volume":"17","author":"Meloni","year":"2011","journal-title":"Mol Vis"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.3390\/ijms19113530","article-title":"Cathepsin S alters the expression of pro-inflammatory cytokines and MMP-9, partially through protease-activated receptor-2, in human corneal epithelial cells.","volume":"19","author":"Klinngam","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/tjo.TJO-D-25-00105","article-title":"Restoring the mucin barrier: advances in secretagogue therapies for ocular surface disorders.","volume":"15","author":"Chuang","year":"2025","journal-title":"Taiwan J Ophthalmol"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1038\/srep10630","article-title":"The oxidant role of 4-hydroxynonenal in corneal epithelium.","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease.","volume":"40","author":"Acera","year":"2008","journal-title":"Ophthalmic Res"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress.","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","article-title":"Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay.","volume":"123","author":"Messmer","year":"2016","journal-title":"Ophthalmology"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41598-025-29319-1","article-title":"Intense pulsed light treatment improved tear film quality and reduced ocular surface inflammation in dry eye patients.","volume":"16","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary.","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report.","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1080\/09273948.2021.1971723","article-title":"Correlation of clinical aqueous flare grading to semi-automated flare measurements using laser flare photometry.","volume":"30","author":"Halim","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3390\/diagnostics12112703","article-title":"Automated quantitative analysis of anterior segment inflammation using swept-source anterior segment optical coherence tomography: a pilot study.","volume":"12","author":"Keino","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ajo.2014.08.015","article-title":"Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.","volume":"158","author":"Lee","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe Juvenile idiopathic arthritis-associated uveitis.","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/OPX.0b013e318255ddc8","article-title":"The impact of tear film components on in vitro lipid uptake.","volume":"89","author":"Lorentz","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"Pt 4","key":"R21-20260707","doi-asserted-by":"crossref","first-page":"146182","DOI":"10.1016\/j.ijbiomac.2025.146182","article-title":"Molecular perspectives on protein-modulated tear film lipid layer stability in dry eye disease.","volume":"320","author":"Cho","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","article-title":"Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.","volume":"30","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"101323","DOI":"10.1016\/j.ajoc.2022.101323","article-title":"Anterior chamber fibrin reaction during descemet membrane endothelial keratoplasty.","volume":"25","author":"Trinh","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10384-023-00995-8","article-title":"Meibomian gland dysfunction clinical practice guidelines.","volume":"67","author":"Amano","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","article-title":"Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction.","volume":"17","author":"Arita","year":"2019","journal-title":"Ocul Surf"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"873538","DOI":"10.3389\/fmed.2022.873538","article-title":"Candidate molecular compounds as potential indicators for meibomian gland dysfunction.","volume":"9","author":"Asiedu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.18240\/ijo.2025.10.05","article-title":"Predictive analysis of dry eye diagnosis and digital screen usage: a cross-sectional study.","volume":"18","author":"Ghimire","year":"2025","journal-title":"Int J Ophthalmol"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"670","DOI":"10.18231\/j.ijceo.9374.1761134872","article-title":"Mitigating eye strain in the digital era: the efficacy of the 20-20-20 rule IJCEO.","volume":"11","author":"Yadav","year":"2025","journal-title":"Indian J Clin Exper Ophthalmol"},{"key":"R29-20260707","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s40123-022-00518-7","article-title":"Effects of a new formulation of multiple-action tear substitute on objective ocular surface parameters and ocular discomfort symptoms in patients with dry eye disease.","volume":"11","author":"Vigo","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1136\/bjophthalmol-2014-305220","article-title":"Randomised masked clinical trial of the MGDRx EyeBag for the treatment of meibomian gland dysfunction-related evaporative dry eye.","volume":"98","author":"Bilkhu","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:00:59Z","timestamp":1783414859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048825","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2026-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}